{"issuance_frequency":"","notes_translated":{"fr":"En août 2003, les négociations entre les membres de l'Organisation mondiale du commerce (OMC) ont mené à une décision historique visant la dérogation de deux dispositions de licence inscrites dans l'Accord sur les aspects des droits de propriété intellectuelle qui touchent au commerce (ADPIC). ","en":"In August 2003, negotiations among  World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems. "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"c10189ae-24a3-4f3c-aad3-e1f3360629a0","metadata_created":"2020-09-17T18:50:33.213310","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-09-17T18:50:33.213316","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-09-17","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Régime canadien d'accès aux médicaments","Organisation mondiale du commerce","dérogation de dispositions de licence","Accord de l'OMC","aspects des droits de propriété intellectuelle qui touchent au commerce","pays en développement et pays les moins développés","importer des médicaments et des instruments médicaux"],"en":["Canada's Access to Medicines Regime","World Trade Organization","waive licensing provisions","WTO Agreement","Intellectual Property Rights","developing and least-developed countries","import high-quality drugs and medical devices"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Contexte du Régime canadien d'accès aux médicaments","en":"Canada's Access to Medicines Regime background"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"c10189ae-24a3-4f3c-aad3-e1f3360629a0","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0dc2b571-db89-44e4-9935-964ce2569030","related_relationship":"","name_translated":{"fr":"Contexte du Régime canadien d'accès aux médicaments","en":"Canada's Access to Medicines Regime background"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canada's Access to Medicines Regime background","language":["en"],"created":"2020-09-17T18:50:33.307925","url":"https://www.canada.ca/en/health-canada/services/canada-access-medicines-regime/introduction/background.html","last_modified":null,"position":0,"revision_id":"8952cc57-d27c-406b-917e-984a9536d551","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"c10189ae-24a3-4f3c-aad3-e1f3360629a0","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"afb71f40-ffb7-402a-af5b-5c5d6e680383","related_relationship":"","name_translated":{"fr":"Contexte du Régime canadien d'accès aux médicaments","en":"Canada's Access to Medicines Regime background"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canada's Access to Medicines Regime background","language":["fr"],"created":"2020-09-17T18:50:33.307931","url":"https://www.canada.ca/fr/sante-canada/services/regime-canadien-acces-medicaments/introduction/contexte.html","last_modified":null,"position":1,"revision_id":"8952cc57-d27c-406b-917e-984a9536d551","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2017-03-28 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"c10189ae-24a3-4f3c-aad3-e1f3360629a0","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"In August 2003, negotiations among  World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems. ","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Canada's Access to Medicines Regime background","revision_id":"8952cc57-d27c-406b-917e-984a9536d551"}